The PML nuclear bodies: actors or extras? - Institut Pasteur Access content directly
Journal Articles Current Opinion in Genetics and Development Year : 1999

The PML nuclear bodies: actors or extras?

Abstract

The PML and SP100-containing nuclear bodies (NBs) represent the best-studied example of a defined nuclear substructure the integrity of which is compromised in certain human diseases, including leukemia, neurodegenerative disorders and viral infection. Although recent progress has underscored the unexpectedly broad involvement of NB constituents in the control of cell growth, gene regulation and apoptosis in both pathological and normal contexts, evidence for a specific physiological activity within the NBs remains scant, thus precluding a unifying hypothesis for NB function.

Dates and versions

pasteur-03237338 , version 1 (26-05-2021)

Identifiers

Cite

Jacob-Sebastian Seeler, Anne Dejean. The PML nuclear bodies: actors or extras?. Current Opinion in Genetics and Development, 1999, 9 (3), pp.362-367. ⟨10.1016/s0959-437x(99)80054-9⟩. ⟨pasteur-03237338⟩

Collections

INSERM PASTEUR
15 View
0 Download

Altmetric

Share

Gmail Facebook Twitter LinkedIn More